bs-1354R [Primary Antibody]
Apolipoprotein J Polyclonal Antibody
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: Apolipoprotein J

Immunogen Range: 331-449/449


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 1191

Swiss Prot: P10909

Source: KLH conjugated synthetic peptide derived from human Apolipoprotein J

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Background:

Isoform 1 functions as extracellular chaperone that prevents aggregation of nonnative proteins. Prevents stress-induced aggregation of blood plasma proteins. Inhibits formation of amyloid fibrils by APP, APOC2, B2M, CALCA, CSN3, SNCA and aggregation-prone LYZ variants (in vitro). Does not require ATP. Maintains partially unfolded proteins in a state appropriate for subsequent refolding by other chaperones, such as HSPA8/HSC7. Does not refold proteins by itself. Binding to cell surface receptors triggers internalization of the chaperone-client complex and subsequent lysosomal or proteasomal degradation. Secreted isoform 1 protects cells against apoptosis and against cytolysis by complement. Intracellular isoforms interact with ubiquitin and SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complexes and promote the ubiquitination and subsequent proteasomal degradation of target proteins. Promotes proteasomal degradation of COMMD1 and IKBKB. Modulates NF-kappa-B transcriptional activity. Nuclear isoforms promote apoptosis. Mitochondrial isoforms suppress BAX-dependent release of cytochrome c into the cytoplasm and inhibit apoptosis. Plays a role in the regulation of cell proliferation.

Size: 100ul

Concentration: 1ug/ul

Applications: ELISA(1:500-1000)
FCM(1:20-100)
IHC-P(1:200-400)
IHC-F(1:100-500)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)

Predicted Molecular Weight: 50


Cross Reactive Species: Human
Mouse
Rat
Others

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Yu, Weihua, et al. "Time-Dependent Decrease of Clusterin as a Potential Cerebrospinal Fluid Biomarker for Drug-Resistant Epilepsy." Journal of Molecular Neuroscience (2014): 1-9.Read more>>
  • Keck, Michael, et al. "A systems level analysis of epileptogenesis-associated proteome alterations." Neurobiology of Disease (2017).Read more>>
  • Xiaojing Zhou. et al. iTRAQ-Based Proteomic Analysis of APP Transgenic Mouse Urine Exosomes. INT J MOL SCI. 2023 Jan;24(1):672Read more>>
  • Martin Schicht. et al. Ocular surface changes in mice with streptozotocin-induced diabetes and diabetic polyneuropathy. OCUL SURF. 2023 DecRead more>>
VALIDATION IMAGES

Formalin-fixed and paraffin embedded tumor tissue labeled with Anti-APOJ/Clusterin-αβ Polyclonal Antibody, Unconjugated (bs-1354R) followed by conjugation to the secondary antibody and DAB staining


Formalin-fixed and paraffin embedded human colon carcinoma labeled with Anti-APOJ/Clusterin Polyclonal Antibody, Unconjugated (bs-1354R) at 1:200 followed by conjugation to the secondary antibody and DAB staining


Formalin-fixed and paraffin embedded rat testis labeled with Anti-APOJ/Clusterin Polyclonal Antibody, Unconjugated (bs-1354R) at 1:200 followed by conjugation to the secondary antibody and DAB staining